Literature DB >> 9257744

Enhancement of bismuth antibacterial activity with lipophilic thiol chelators.

P Domenico1, R J Salo, S G Novick, P E Schoch, K Van Horn, B A Cunha.   

Abstract

The antibacterial properties of bismuth are greatly enhanced when bismuth is combined with certain lipophilic thiol compounds. Antibacterial activity was enhanced from 25- to 300-fold by the following seven different thiols, in order of decreasing synergy: 1,3-propanedithiol, dimercaprol (BAL), dithiothreitol, 3-mercapto-2-butanol, beta-mercaptoethanol, 1-monothioglycerol, and mercaptoethylamine. The dithiols produced the greatest synergy with bismuth at optimum bismuth-thiol molar ratios of from 3:1 to 1:1. The monothiols were generally not as synergistic and required molar ratios of from 1:1 to 1:4 for optimum antibacterial activity. The most-active mono- or dithiols were also the most soluble in butanol. The intensity of the yellow formed by bismuth-thiol complexes reflected the degree of chelation and correlated with antibacterial potency at high molar ratios. The bismuth-BAL compound (BisBAL) was active against most bacteria, as assessed by broth dilution, agar diffusion, and agar dilution analyses. Staphylococci (MIC, 5 to 7 microM Bi3+) and Helicobacter pylori (MIC, 2.2 microM) were among the most sensitive bacteria. Gram-negative bacteria were sensitive (MIC, < 17 microM). Enterococci were relatively resistant (MIC, 63 microM Bi3+). The MIC range for anaerobes was 15 to 100 microM Bi3+, except for Clostridium difficile (MIC, 7.5 microM). Bactericidal activity averaged 29% above the MIC. Bactericidal activity increased with increasing pH and/or increasing temperature. Bismuth-thiol solubility, stability, and antibacterial activity depended on pH and the bismuth-thiol molar ratio. BisBAL was stable but ineffective against Escherichia coli at pH 4. Activity and instability (reactivity) increased with increasing alkalinity. BisBAL was acid soluble at a molar ratio of greater than 3:2 and alkaline soluble at a molar ratio of less than 2:3. In conclusion, certain lipophilic thiol compounds enhanced bismuth antibacterial activity against a broad spectrum of bacteria. The activity, solubility, and stability of BisBAL were strongly dependent on the pH, temperature, and molar ratio. Chelation of bismuth with certain thiol agents enhanced the solubility and lipophilicity of this cationic heavy metal, thereby significantly enhancing its potency and versatility as an antibacterial agent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257744      PMCID: PMC163988     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  Biological activity of organometallic bismuth compounds.

Authors:  T Klapötke
Journal:  Biol Met       Date:  1988

Review 2.  Bismuth subsalicylate: history, chemistry, and safety.

Authors:  D W Bierer
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

3.  In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts.

Authors:  M D Manhart
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

Review 4.  Campylobacter pylori: its link to gastritis and peptic ulcer disease.

Authors:  B J Marshall
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

5.  Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa.

Authors:  P Domenico; R O'Leary; B A Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

6.  Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.

Authors:  D Y Graham; G M Lew; D G Evans; D J Evans; P D Klein
Journal:  Ann Intern Med       Date:  1991-08-15       Impact factor: 25.391

7.  Enhanced bismuth digestive absorption in rats by some sulfhydryl compounds: nmr study of complexes formed.

Authors:  D Chaleil; F Lefevre; P Allain; G J Martin
Journal:  J Inorg Biochem       Date:  1981-11       Impact factor: 4.155

8.  Bismuth subcitrate and omeprazole inhibit Helicobacter pyloriF1-ATPase.

Authors:  W Beil; C Birkholz; S Wagner; K F Sewing
Journal:  Pharmacology       Date:  1995-05       Impact factor: 2.547

9.  In vitro antibacterial activity of bismuth subsalicylate.

Authors:  N A Cornick; M Silva; S L Gorbach
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

Review 10.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
View more
  15 in total

1.  Topical Antimicrobials in Burn Care: Part 1-Topical Antiseptics.

Authors:  Janos Cambiaso-Daniel; Stafanos Boukovalas; Genevieve H Bitz; Ludwik K Branski; David N Herndon; Derek M Culnan
Journal:  Ann Plast Surg       Date:  2018-01-09       Impact factor: 1.539

2.  Interaction of bismuth subsalicylate with fruit juices, ascorbic acid, and thiol-containing substrates to produce soluble bismuth products active against Clostridium difficile.

Authors:  D E Mahony; A Woods; M D Eelman; N Burford; S J O Veldhuyzen van Zanten
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 3.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

4.  Activities of bismuth thiols against staphylococci and staphylococcal biofilms.

Authors:  P Domenico; L Baldassarri; P E Schoch; K Kaehler; M Sasatsu; B A Cunha
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

Review 5.  Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Authors:  Eric Wenzler; Dustin R Fraidenburg; Tonya Scardina; Larry H Danziger
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

6.  Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.

Authors:  Moayad Alhariri; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

7.  Inhibition of bacterial adherence on the surface of stents and bacterial growth in bile by bismuth dimercaprol.

Authors:  Hongjun Zhang; Javon Tang; Xangwen Meng; Jackie Tsang; Tat-Kin Tsang
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

8.  Antibacterial properties of some cyclic organobismuth(III) compounds.

Authors:  Toshiaki Kotani; Daisuke Nagai; Kensuke Asahi; Hitomi Suzuki; Fumiaki Yamao; Nobumasa Kataoka; Tatsuo Yagura
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

9.  Antimicrobial activities of synthetic bismuth compounds against Clostridium difficile.

Authors:  D E Mahony; S Lim-Morrison; L Bryden; G Faulkner; P S Hoffman; L Agocs; G G Briand; N Burford; H Maguire
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

10.  Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide.

Authors:  P Domenico; J M Tomas; S Merino; X Rubires; B A Cunha
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.